Pituitary hormones
Hormone mechanisms, feedback, hypothalamus and pituitary: GH, prolactin, ADH, oxytocin
Water-soluble hormones act through surface receptors and second messengers; steroids and thyroid hormone act on nuclear receptors. Covers hypothalamic nuclei, portal control of the anterior pituitary, GH, prolactin, puberty, pituitary disease and post-surgical DI.
How hormones act
| Receptor type | Second messenger | Examples |
|---|---|---|
| G-protein coupled, Gs | ↑ cAMP | ACTH, TSH, LH, FSH, PTH, glucagon, ADH (V2), calcitonin, hCG, CRH, GHRH, beta-adrenergic |
| G-protein coupled, Gi | ↓ cAMP | Somatostatin, alpha-2, M2, D2 (dopamine) |
| G-protein coupled, Gq | IP₃, DAG, Ca²⁺ | GnRH, TRH, oxytocin, ADH (V1, vasoconstriction), angiotensin II, alpha-1, M1 and M3 |
| Receptor tyrosine kinase | Intrinsic kinase | Insulin, IGF-1, growth factors |
| Cytokine receptor with JAK–STAT | Associated kinase | Growth hormone, prolactin, erythropoietin, thrombopoietin, leptin |
| Guanylyl cyclase | cGMP | ANP (from stretched atria; natriuresis), BNP, nitric oxide |
| Intracellular (nuclear) receptor | Gene transcription | Steroids, thyroid hormone (receptor in the nucleus), vitamin D, retinoic acid |
- Peptides and catecholamines circulate free and act in seconds to minutes. Steroids and thyroid hormones travel bound to carriers (only the free fraction is active) and act over hours by changing protein synthesis.
- An activating Gs-alpha (GNAS) mutation in a mosaic pattern causes McCune–Albright syndrome: peripheral precocious puberty (suppressed LH and FSH), irregular café-au-lait patches and fibrous dysplasia, because Gs-linked receptors signal without their hormone.
Feedback
- Negative feedback is the commonest and most important control: each end hormone suppresses its hypothalamic and pituitary drivers. Primary gland failure therefore gives a high pituitary hormone (primary hypothyroidism: high TSH, low T4), while pituitary failure gives a low or inappropriately normal one.
- Positive feedback examples: the oestrogen-triggered LH surge (LH rises about 6–10-fold over the 1–2 days before ovulation), oxytocin in labour (Ferguson reflex), clotting cascade, and action potential upstroke.
- In males, inhibin from Sertoli cells inhibits FSH; testosterone inhibits LH.
- A TSH within the normal range is abnormal if free T4 is clearly high: think of a TSH-secreting pituitary adenoma (or thyroid hormone resistance).
Hypothalamic nuclei
| Nucleus | Function | Lesion |
|---|---|---|
| Supraoptic (and paraventricular) | ADH (supraoptic mainly) and oxytocin (paraventricular mainly) | Central diabetes insipidus |
| Ventromedial | Satiety centre | Hyperphagia and obesity |
| Lateral | Hunger centre | Anorexia, starvation |
| Suprachiasmatic | Circadian clock (retinal input); drives pineal melatonin | Disrupted sleep–wake rhythm |
| Arcuate | GHRH, dopamine (prolactin-inhibiting), GnRH neurones, leptin target | |
| Anterior (preoptic) | Heat loss (sweating, vasodilatation); osmoreceptors and thirst (OVLT) | Hyperthermia |
| Posterior | Heat conservation and production | Poikilothermia |
| Paraventricular | CRH, TRH, oxytocin, ADH |
Melatonin from the pineal gland is secreted mainly in darkness (light inhibits it via the retina and suprachiasmatic nucleus); it promotes sleep and can suppress gonadotrophins.
The hypothalamic–pituitary connections
- Anterior pituitary (from Rathke's pouch, oral ectoderm): hypothalamic hormones reach it through the hypophyseal portal veins in the stalk.
- Posterior pituitary (neural ectoderm): ADH and oxytocin are made in hypothalamic neurones (neurosecretion), carried down axons with neurophysins, stored and released. ADH and its stable co-product copeptin come from one precursor (neurophysin II); oxytocin uses neurophysin I.
| Hypothalamic hormone | Effect on anterior pituitary |
|---|---|
| TRH | ↑ TSH, ↑ prolactin |
| CRH | ↑ ACTH |
| GnRH (pulsatile) | ↑ LH, FSH; continuous GnRH (agonist depot) suppresses them (prostate cancer, endometriosis, central precocious puberty) |
| GHRH | ↑ GH |
| Somatostatin | ↓ GH, ↓ TSH |
| Dopamine | ↓ prolactin: prolactin is under tonic inhibition |
Anterior pituitary hormones
| Hormone | Cell | Main actions |
|---|---|---|
| GH | Somatotroph (commonest, about 50%) | Liver IGF-1 (somatomedin C) mediates growth of bone and muscle; directly raises glucose (anti-insulin), lipolysis, protein synthesis |
| Prolactin | Lactotroph | Milk production; suppresses GnRH |
| ACTH | Corticotroph (POMC, which also gives MSH) | Cortisol, adrenal androgens; stimulates the rate-limiting step of steroid synthesis, cholesterol entry into mitochondria (StAR) and side-chain cleavage to pregnenolone |
| TSH | Thyrotroph | Thyroid hormone synthesis and gland growth |
| LH, FSH | Gonadotroph | Gonadal steroids, ovulation, spermatogenesis |
Growth hormone
- Pulsatile; the largest pulse is in early slow-wave (deep) sleep. (Cortisol peaks in the early morning.)
- Increased by deep sleep, exercise, stress, fasting, hypoglycaemia, arginine and amino acids, puberty, ghrelin. Decreased by hyperglycaemia, somatostatin, IGF-1 feedback, obesity, cortisol excess.
- GH needs IGF-1 for most of its growth actions.
- The early-morning GH and cortisol surge raises fasting glucose in type 1 diabetes (dawn phenomenon), with normal 3 a.m. readings.
- Acromegaly (excess after epiphyseal fusion): enlarging hands, feet, jaw and tongue, sweating, hypertension, diabetes, bitemporal field loss. Screen with serum IGF-1; confirm with failure of GH to suppress during an oral glucose tolerance test. A random GH is unhelpful. Excess before fusion causes gigantism.
Prolactin
- Raised by pregnancy, suckling, stress, sleep, primary hypothyroidism (TRH), renal failure, dopamine D2 antagonists (risperidone and other antipsychotics, metoclopramide, domperidone), and stalk compression, which cuts the dopamine supply. Prolactin is the one anterior pituitary hormone that rises when the stalk is cut.
- High prolactin suppresses GnRH: amenorrhoea, galactorrhoea, infertility, low libido.
- Macroprolactin (prolactin bound to IgG) is biologically inactive but measured by assays: a high prolactin with regular periods, no galactorrhoea and normal MRI. Exclude it before treatment.
- Prolactinomas are treated first with dopamine agonists (cabergoline, bromocriptine).
Posterior pituitary
- ADH: water reabsorption (V2) and vasoconstriction (V1).
- Oxytocin: uterine contraction in labour and milk ejection (let-down) on suckling.
- Damage to the posterior pituitary or stalk reduces ADH (and oxytocin).
Puberty and gonadotrophins
| Pattern | LH and FSH | Cause |
|---|---|---|
| Central precocious puberty | Raised, rise further after GnRH | Early activation of GnRH pulses (idiopathic in girls; CNS lesion) |
| Peripheral precocious puberty | Suppressed | McCune–Albright, adrenal or ovarian tumour, CAH |
| Kallmann syndrome | Low | Failed migration of GnRH neurones with the olfactory placode: delayed puberty with anosmia |
| Functional hypothalamic amenorrhoea | Low | Stress, weight loss, excessive exercise suppress GnRH pulsatility |
Pituitary disease
- Pituitary apoplexy: haemorrhage into an adenoma, with sudden headache, vomiting, diplopia, visual loss, hypotension and hyponatraemia. Give IV hydrocortisone first; always replace cortisol before thyroxine.
- Sheehan syndrome: postpartum pituitary infarction after major haemorrhage; failure of lactation is often the first sign.
- Order of hormone loss with an expanding mass: GH and gonadotrophins first, then TSH, then ACTH; prolactin rises.
- Bitemporal hemianopia: chiasmal compression from below. Craniopharyngioma: Rathke's pouch remnant, calcified suprasellar mass in children.
Sodium problems after pituitary or brain injury
- Triphasic response after pituitary surgery: (1) cranial DI from shocked neurones (polyuria, dilute urine, rising sodium; give desmopressin); (2) about days 5–10, SIADH from unregulated ADH leaking from degenerating axons (desmopressin now causes dangerous hyponatraemia); (3) permanent DI once stores are exhausted.
- Cerebral salt wasting (after subarachnoid haemorrhage): natriuretic peptides cause renal salt loss, so the patient is hypovolaemic (weight loss, postural hypotension, rising urea and haematocrit) with high urine sodium. SIADH looks the same in the urine but the patient is euvolaemic. Treat salt wasting with saline; fluid restriction worsens vasospasm.
Remember Portal blood drives the front of the pituitary, axons fill the back; dopamine holds prolactin down; IGF-1 screens for acromegaly.
Exam trap Prolactin is controlled by dopamine inhibition; antipsychotics and stalk compression raise it.
Exam trap Insulin uses a tyrosine kinase; GH and prolactin use JAK–STAT; thyroid hormone uses a nuclear receptor.
How FCPS asks about this
- Posterior pituitary hormones: ADH and oxytocin, made in supraoptic and paraventricular nuclei.
- Lesion causing hyperphagia and obesity: ventromedial nucleus (satiety centre).
- Acromegaly: IGF-1 to screen; GH not suppressed by oral glucose to confirm.
- Galactorrhoea on risperidone: D2 blockade on lactotrophs removes dopamine inhibition.
- Delayed puberty with anosmia: Kallmann syndrome (low GnRH).
- GH peak: early slow-wave sleep; melatonin peaks in darkness.
- Hyponatraemia day 7 after pituitary surgery: ADH leaking from degenerating axons (second phase of the triphasic response).
Test yourself on this topic
5 of the 133 questions in our bank on this topic. Choose an answer to see why every option is right or wrong.
A man with type 1 diabetes has high fasting glucose at 7 a.m. but normal readings at 3 a.m. without hypoglycaemia. What explains this?
Answer: Dawn phenomenon
The dawn phenomenon is early-morning hyperglycaemia caused by the circadian rise of counter-regulatory hormones (growth hormone, cortisol, catecholamines) between about 4 and 8 a.m., increasing hepatic glucose output and insulin resistance; 3 a.m. glucose is normal. Management: adjust basal insulin timing or dose, or use an insulin pump. The Somogyi effect (rebound hyperglycaemia after nocturnal hypoglycaemia) shows low 3 a.m. glucose and is managed by reducing the evening dose; continuous glucose monitoring shows it is uncommon.
Morning hyperglycaemia
- Dawn phenomenon: GH, cortisol surge; 3 a.m. normal
- Somogyi: 3 a.m. hypo → rebound
- Check 3 a.m. glucose to tell apart
Remember Check at three to know which it is.
Why the other options are wrong
- Somogyi effect Would show low 3 a.m. glucose.
- Excess evening insulin Would cause nocturnal hypoglycaemia.
- Insulin antibodies Not this pattern.
- Renal failure Not this pattern.
A 70-year-old man with severe heart failure has oedema and sodium 125 mmol/L with low plasma osmolality. Urine osmolality is inappropriately high. Which of the following best explains his hyponatraemia?
Answer: Non-osmotic ADH release from low arterial filling
In heart failure, low cardiac output reduces the effective arterial blood volume sensed by baroreceptors in the carotid sinus and aortic arch. This signal releases ADH even when plasma osmolality is low, because a large fall in effective volume overrides osmotic control. Water is retained in excess of sodium, causing dilutional hyponatraemia; the same happens in cirrhosis. Aldosterone retains sodium with water and causes oedema, but by itself does not lower sodium. Worsening hyponatraemia in heart failure carries a poor prognosis.
ADH in heart failure
- Low cardiac output: baroreceptors fire less
- ADH released despite low osmolality
- Water kept more than sodium
- Same in cirrhosis
Remember Volume beats osmolality when the fall is large.
Exam trap Oedema means total sodium is high; the low sodium reflects extra water.
Why the other options are wrong
- Ectopic ADH secretion by a tumour No tumour is suggested; heart failure explains it.
- Aldosterone retaining sodium more than water Aldosterone retains salt and water together.
- Loss of sodium in sweat Not a cause of this picture.
- Adrenal insufficiency from congestion Not a feature of heart failure.
Growth hormone, prolactin and erythropoietin act through which signalling pathway?
Answer: JAK–STAT
Receptors for GH, prolactin, erythropoietin, thrombopoietin, G-CSF, leptin and many interleukins and interferons have no kinase activity of their own; they associate with Janus kinases (JAKs), which phosphorylate STAT proteins that move to the nucleus to change transcription. A JAK2 V617F mutation drives polycythaemia vera and other myeloproliferative neoplasms; JAK inhibitors (ruxolitinib, tofacitinib) are used therapeutically.
JAK-STAT
- GH, prolactin, EPO, G-CSF, leptin, cytokines
- JAK2 V617F: polycythaemia vera
- Inhibitors: ruxolitinib, tofacitinib
Remember Growth and blood signals ride the JAK.
Why the other options are wrong
- cAMP Glucagon, ACTH, TSH, PTH.
- IP3 and DAG Oxytocin, ADH (V1), GnRH.
- Nuclear steroid receptor Steroids, thyroid hormone, vitamin D.
- Guanylate cyclase ANP, nitric oxide.
A 30-year-old woman is found to have a prolactin of 2,400 mU/L on a routine infertility screen. Her periods are regular, she has no galactorrhoea, she takes no drugs, TSH is normal and pituitary MRI is normal. Her partner has a low sperm count. Which of the following is the most likely explanation for her prolactin result?
Answer: Macroprolactin (prolactin–IgG complex)
Macroprolactin is prolactin bound to IgG. The large complex is cleared slowly by the kidney, so it builds up in the blood and is detected by most prolactin immunoassays, but it barely crosses capillary walls and so has little biological activity. It is a common cause of a raised prolactin in people without symptoms. The laboratory detects it by polyethylene glycol precipitation, which removes the complex and leaves the true monomeric prolactin. Recognising it avoids unnecessary MRI scans and dopamine agonist treatment.
Macroprolactin
- Prolactin bound to IgG
- Slow clearance, so the level looks high
- Little biological activity
- Detect by PEG precipitation
Remember High prolactin with no symptoms: ask the lab about macroprolactin.
Exam trap Do not start a dopamine agonist for a raised prolactin without symptoms until macroprolactin is excluded.
Why the other options are wrong
- Microprolactinoma Would usually disturb the cycle or cause galactorrhoea.
- Pituitary stalk compression Needs a mass; MRI is normal.
- Primary hypothyroidism Excluded by the normal TSH.
- Physiological rise of early pregnancy Periods are regular, so pregnancy is unlikely.
A 5-year-old girl has vaginal bleeding, breast development, large irregular café-au-lait patches and fibrous dysplasia of the femur. LH and FSH are suppressed. Which molecular defect best explains her condition?
Answer: Activating Gs alpha (GNAS) mutation
McCune–Albright syndrome is caused by a post-zygotic activating mutation of GNAS, so the Gs alpha subunit loses its GTPase activity and keeps adenylate cyclase switched on. Every cell carrying the mutation behaves as if its Gs-coupled hormone receptor were always stimulated: ovarian cells make oestrogen autonomously (peripheral precocious puberty with suppressed LH and FSH), melanocytes make pigment, and bone shows fibrous dysplasia. Because the mutation is mosaic, the features are patchy. Central puberty would show raised gonadotrophins.
McCune–Albright
- GNAS activating mutation (mosaic)
- Gs always on: cAMP keeps rising
- Puberty with suppressed LH/FSH
- Café-au-lait + fibrous dysplasia
Remember Hormone signal stuck on without the hormone.
Exam trap Suppressed gonadotrophins mean the puberty is peripheral, not hypothalamic.
Why the other options are wrong
- Loss of function of the LH receptor Would reduce, not increase, sex hormone production.
- Early pulsatile GnRH secretion Central puberty: LH and FSH would be raised.
- Deletion of the SRY gene Affects sex determination, not this triad.
- Inactivating mutation of the NF1 gene NF1 patches are smooth-edged; no autonomous puberty.
Where this sits in the CPSP syllabus
- Paper 1: Endocrinology, Hormone mechanisms; hypothalamus and pituitary (GH, prolactin, ADH, oxytocin)
- Surgery & Allied, Paper 2: Endocrinology, Hormone mechanisms; hypothalamus and pituitary (GH, prolactin, ADH, oxytocin)
- Medicine & Allied, Paper 2: Endocrinology, Hormone mechanisms; hypothalamus and pituitary (GH, prolactin, ADH, oxytocin)
Read next
Drug dose pages
Doses, cautions and practical tips for drugs in this chapter.